Treatment | Day of initial treatment or re-infestation1 | |||||||
---|---|---|---|---|---|---|---|---|
0 | 14 | 29 | 44 | 59 | 74 | 90 | ||
Placebo | Range | 44–94 | 71–86 | 39–96 | 48–93 | 35–91 | 58–93 | 30–71 |
A. mean | 75.0 | 75.5 | 73.1 | 70.8 | 72.5 | 72.4 | 56.1 | |
G. mean2 | 73.3a | 75.4a | 70.2a | 69.0a | 69.5a | 71.4a | 54.5a | |
Sarolaner | Range | 0–0 | 0–0 | 0–8 | 0–0 | 0–2 | 0–0 | 0–1 |
A. mean | 0.0 | 0.0 | 1.8 | 0.0 | 0.5 | 0.0 | 0.1 | |
Efficacy (%) | 100 | 100 | 97.6 | 100 | 99.3 | 100 | 99.8 | |
G. mean2 | 0.0b | 0.0b | 1.0b | 0.0b | 0.4b | 0.0c | 0.1c | |
Efficacy (%) | 100 | 100 | 98.6 | 100 | 99.5 | 100 | 99.8 | |
P-value vs. placebo | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
Fluralaner | Range | 0–0 | 0–1 | 0–4 | 0–0 | 0–19 | 0–54 | 0–63 |
A. mean | 0.0 | 0.1 | 0.6 | 0.0 | 2.6 | 14.0 | 15.4 | |
Efficacy (%) | 100 | 99.8 | 99.1 | 100 | 96.4 | 80.7 | 72.6 | |
G. mean2 | 0.0b | 0.1b | 0.3b | 0.0b | 0.7b | 7.1b | 4.0b | |
Efficacy (%) | 100 | 99.9 | 99.5 | 100 | 99.0 | 90.0 | 92.7 | |
P-value vs. placebo | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
P-value vs. sarolaner | 1.000 | 0.3311 | 0.2334 | 1.0000 | 0.4991 | <0.0001 | 0.0043 |